Company intelligence / Profile preview

Unicorn Capital Partners

Moscow, Moscow, Russiaunicorn-partners.com ↗

Ownership: Private
Development stage: Other

Overview

Unicorn Capital Partners is an active venture capital and fund-of-funds management firm specializing in investments in the life sciences sector—including biotechnology startups, pharmaceutical development, medical devices, diagnostics, and health IT. The firm manages the PharmMed Innovations venture fund and focuses on supporting breakthrough scientific ideas to become globally accessible products. It has invested in numerous companies that have gone public or been acquired.

Modalities: Small moleculeBiologicCell therapyGene therapy
Industry: Investors

Partnerships

Third Rock VenturesJJDC (Johnson & Johnson)Frazier Life SciencesBessemer Venture PartnersForbionPfizer VenturesHBM Healthcare InvestmentsTVM CapitalAvalon Ventures

Beyond the preview

Go deeper on Unicorn Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unicorn Capital Partners.

Explore the full profile